Clinical trial
An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose…
NCT00270543 · Far Eastern Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00270543 |
|---|---|
| Title | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer |
| Official title | A Phase II Study of Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin(HDFL)for Inoperable Advanced or Metastatic Gastric Cancer |
| Lead sponsor | Far Eastern Memorial Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stomach Neoplasms |
| Intervention type | Drug |
| Interventions | Taxotere, Fluorouracil, Leucovorin |
| Enrollment | 54 |
| First posted | Dec 28, 2005 |
| Last update posted | Feb 9, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: